Patrick Soon-Shiong Biography
Patrick Soon-Shiong is a South African-American transplant surgeon, business billionaire, bioscientist, and media mogul. He created the drug Abraxane, which became well-known for its effectiveness against lung, breast, and pancreatic cancer. He has more than 100 scientific papers to his credit, as well as more than 230 issued patents on advancements in technology and medicine.
How old is Patrick Soon-Shiong? – Age
He is 69 years old as of 29 July 2021. He was born in 1952 in Gqeberha, South Africa.
Patrick Soon-Shiong Family
Soon was born to Chinese immigrant parents who fled China during World War II’s Japanese occupation. His parents were Hakka from Guangdong province’s Mei County. Huang () is his ancestor’s surname.
Who is Patrick Soon-Shiong wife? – Marriage
Patrick is married to Michele B. Chan, a former actress. They live in Los Angeles, California, with their two children.
What school did Patrick Soon Shiong go to? – Education
At the age of 23, he graduated fourth in his class of 189 from the University of Witwatersrand with a bachelor’s degree in medicine (MBBCh). He finished his medical internship at the General Hospital in Johannesburg. He then went on to study at the University of British Columbia, where he received a master’s degree in 1979, as well as research grants from the American College of Surgeons, the Royal College of Physicians and Surgeons of Canada, and the American Association of Academic Surgery.
He immigrated to the United States and began surgical training at the University of California, Los Angeles (UCLA), where he eventually became a board-certified surgeon in 1984. Shiong is a Fellow of both the Royal College of Surgeons of Canada and the American College of Surgeons.
What is Patrick Soon Shiong net worth?
He has an estimated net worth of 8.5 billion USD. He sold Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a total of $9.1 billion. His company, NantEnergy, announced in September 2018 the development of a zinc air battery with a projected cost of $100 per kilowatt-hour.
How much does Patrick Soon Shiong make? – Salary
The Los Angeles Times reported in April 2016 that Soon-Shiong received a pay package from NantKwest worth nearly $148 million in 2015, making him one of the highest-paid CEOs.
Patrick Soon Shiong House
He’s been irritating a quiet “upper-middle-class” Brentwood neighborhood (below Sunset!) for the past few years with the construction of a three-acre compound. Soon-Shiong lived in the neighborhood when he was just rich (not superrich), and in 2006 he began buying up house after house, eventually spending $29 million. The Los Angeles Times reported in 2010 that “crews have been moving dirt, filling in pools, and erecting building frames.” Trees have been uprooted and transplanted to new locations.
One massive wood-sided hole appears to be the footprint of a planned 3,300-square-foot basement… part of an 18,000-square-foot addition to an existing single-family home.” Meanwhile, more neighbors said they had turned down offers to sell from agents thought to be representing Soon-Shiong. Construction was expected to take several years at the time, but Soon-Shiong and his family were living “amid it all on a 0.6-acre property” in the meantime.
How did Patrick Soon-Shiong make his money? – Career
Shiong joined the faculty of UCLA Medical School in 1983 and worked as a transplant surgeon until 1991. He performed the first whole-pancreas transplant, as well as developing and implementing the experimental Type 1 diabetes treatment known as encapsulated-human-islet transplant and performing the “first pig-to-man islet-cell transplant in diabetic patients.” In 1991, he left UCLA to found VivoRx Inc., a diabetes and cancer biotechnology firm, which led to the formation of APP Pharmaceuticals, which he sold to Fresenius SE for $4.6 billion in 2008.
In 1998, he bought Fujisawa, a company that sold injectable generic drugs, and used the proceeds to develop Abraxane, which wrapped an existing chemotherapy drug, Taxol, in protein to make it easier to deliver to tumors. Shiong co-founded NantHealth to provide fiber-optic, cloud-based data infrastructure to sequencing centers, medical research hubs, and hospitals. His vision for cancer treatment in the future was a convergence of multiple technologies such as diagnostics, supercomputing, network modeling of sharing data on tumor genes, and personalized cocktails of cancer drugs in multi-target attacks.
He put $2.5 million into the first round of funding for AccuRadio, an online streaming music service, in 2014. In 2015, he launched an IPO for NantKwest (formerly ConkWest) that was the highest-valued biotech IPO in history, with a $2 billion market cap. Shiong made a $12 million donation to the University of Utah, which sparked media scrutiny and allegations that the foundation engaged in illegal transactions. The US Internal Revenue Service completed its audit of the donation on May 29, 2019, and found no violations.
In 2016, he established the National Immunotherapy Coalition to encourage rival pharmaceutical companies to collaborate in testing cancer-fighting drug combinations. He has met with former Vice President and current US President Joe Biden several times to discuss more ambitious cancer-fighting strategies.